Autopsy report · NCT00472771

INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

“Terminated due to clinical trial material production delays”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

CytRx

Sponsor type

Industry

Conditions

Small Cell Lung Cancer

Interventions

INNO-206

Participants

0

Sites

7

Countries

United States

Trials that died the same way

• Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME)
  “The clinical trial was terminated ahead of schedule due to strategic changes within the company.” (79% match in meaning)
• Low-dose Gonal-f® in Ovulation Induction
  “Study was terminated because of delays in sourcing replacement Investigational Medicinal Product for the study due to manufacturing delays.” (72% match in meaning)
• Avelumab and Radiation in Muscle-Invasive Bladder Cancer
  “In agreement with the drug sponsor and the institution, the trial has been terminated due to slow accrual.” (71% match in meaning)
• BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial
  “Company was sold and clinical trial was suspended then teminated” (70% match in meaning)
• Pancreatic Enzyme Supplementation for Celiac Disease
  “The trial was terminated prematurely by the sponsor for administrative reasons.” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.